Dry Eye Disease (TFOS DEWS II Report)

Dry eye disease (DED) affects hundreds of millions of people throughout the world and is one of the most frequent causes of patient visits to eye care practitioners. It is a symptomatic disease, characterized by a vicious cycle which leads to increased inflammation, damage and neurosensory abnormalities. Moderate to severe DED is associated with significant pain, limitations in performing daily activities, reduced vitality, poor general health, and often depression.

Sarah Farrant presenting at DEWS IIThe Tear Film and Ocular Surface Society (TFOS) have recently published a report (called DEWS II) of the results of the efforts of 150 clinical and basic science research experts from around the world at an event in London. The clinicians utilised an evidence-based approach and a process of open communication, dialogue and transparency to increase our understanding of DED. This process required more than 2 years to complete.

Earlam and Christophers own Sarah Farrant, the UK’s Ambassador for TFOS, and acknowledged Dry Eye Disease specialist, presented the report findings to 70 attendees at the first of a series of roadshows at the London event.

Sarah spoke on ‘What does DEWS II mean for me in my practice?’ helping other practitioners to understand:

  • which features of the tear film and ocular surface should be assessed in modern dry eye disease diagnosis and management (in line with TFOS DEWS II),
  • a step-wise approach to a management plan for patients with dry eye, based on the recommendations from DEWS II,
  • how to help patients with self-care
  • how to communicate about how the chronic condition of dry eye can be managed.

For more information on the TFOS DEWS 11 report visit: http://www.tfosdewsreport.org/